Fluvastatin mitigates SARS-CoV-2 infection in human lung cells
Zapatero-Belinchon, F. J.; Moeller, R.; Lasswitz, L.; van Ham, M.; Becker, M.; Brogden, G.; Rosendal, E.; Bi, W.; Carriqui, B.; Islam, K.; Lenman, A.; Gunesch, A. P.; Kirui, J.; Pietschmann, T.; Overby, A. K.; Jaensch, L.; Gerold, G.
Show abstract
The retrospective analysis of clinical data of patients suffering from COVID-19 has indicated that statin therapy, used to lower plasma cholesterol levels, is associated with a better clinical outcome. We therefore investigated the effect of statins on SARS-CoV-2 infection and found that selective statins reduced SARS-CoV-2 cell entry and inhibited high and low pathogenic coronavirus infection in human cells. A retrospective study on hospitalized patients with COVID-19 implies that reduced high density lipoprotein levels, which are typically counteracted by statin therapy, are associated with aggravated disease outcome. These results suggest that statin therapy poses no additional risk to individuals exposed to SARS-CoV-2 and that some statins may have a mild beneficial effect on COVID-19 outcome. Placebo controlled trials are required to clarify the role of statins in COVID-19 infected patients.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Dimerization of kringle 1 domain from hepatocyte growth factor/scatter factor provides a potent minimal MET receptor agonist. 94%
- Topical TMPRSS2 inhibition prevents SARS-CoV-2 infection in differentiated primary human airway cells 93%
- BRD2 regulation of sigma-2 receptor expression upon cytosolic cholesterol deprivation 92%
Similar papers in this journal
- Dual RNA-Seq analysis of SARS-CoV-2 correlates specific human transcriptional response pathways directly to viral expression 94%
- Nebulized 2-deoxylated glucose analogues inhibit respiratory viral infection in advanced in vitro airway models 94%
- Integrin activation is an essential component of SARS-CoV-2 infection 94%
Similar papers in this journal
- A global lipid map reveals host dependency factors conserved across SARS-CoV-2 variants 95%
- Identification of SARS-CoV2-mediated suppression of NRF2 signaling reveals a potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarate 94%
- Characterization and structural basis of a lethal mouse-adapted SARS-CoV-2 94%
Similar papers in this journal
- Evaluation of SARS-CoV-2 Entry, Inflammation and New Therapeutics in Human Lung Tissue Cells 95%
- Characterisation of the Semliki Forest Virus-host cell interactome reveals the viral capsid protein as an inhibitor of nonsense-mediated mRNA decay 94%
- Glycosylated extracellular mucin domains protect against SARS CoV-2 infection at the respiratory surface 94%
Similar papers in this journal
- Hypoxia inducible factors inhibit respiratory syncytial virus infection by modulation of nucleolin expression 96%
- Spatiotemporally organized immunomodulatory response to SARS-CoV-2 virus in primary human broncho-alveolar epithelia 95%
- Secreted ORF8 is a pathogenic cause of severe Covid-19 and potentially targetable with select NLRP3 inhibitors 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.